user-group INVESTOR ACCESS
Search
Close this search box.
  1. Home
  2. /
  3. Venture Capital
  4. /
  5. Deepull appoints Didier Deltort...

News / Venture Capital

Deepull appoints Didier Deltort to its Board of Directors.

22 May 2024
Deepull, a medical diagnostics company developing culture-free diagnostic solutions for rapid pathogen identification for sepsis and other acute infections, today announces the appointment of Didier Deltort to its Board of Directors.

Download

Press Release
Download

Related News

  • Buyout
Icone-Merieux-partners
  • Buyout

Mérieux Equity Partners announces two promotions to strengthen its Buyout Team

arrow-up-right
  • Buyout
GTP_Bioways_3-vector
  • Recent investments & divestments

Mérieux Equity Partners announces the sale of the French Contract Developing and Manufacturing Organisation GTP Bioways to the Italian company Olon Group

arrow-up-right
  • Buyout
labquality logo
  • Recent investments & divestments

Labquality strengthens its regulatory affairs service capabilities and expands to Sweden.

arrow-up-right
Lyon
Paris
Contact
  • ⓒ MERIEUX EQUITY PARTNERS 2023
  • Mérieux Equity Partners vehicles are only open to Professional Clients - as defined in the French Monetary code (CMF) and AMF regulation (RG).